CHEMINFORMATICS.ORG
Today's Pharma Headlines: AbbVie's pan-genotypic HCV regimen achieves 99% cure rate in phase 3 study - H3 Biomedicine, Foundation Medicine extend precision oncology collaboration - Immune Pharmaceuticals licenses cancer treatment's Latin America rights to Pint - ...